These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 23665275)
1. Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women. Samadder NJ; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ Gastroenterology; 2013 Aug; 145(2):348-56.e1-2. PubMed ID: 23665275 [TBL] [Abstract][Full Text] [Related]
2. Association between molecular subtypes of colorectal cancer and patient survival. Phipps AI; Limburg PJ; Baron JA; Burnett-Hartman AN; Weisenberger DJ; Laird PW; Sinicrope FA; Rosty C; Buchanan DD; Potter JD; Newcomb PA Gastroenterology; 2015 Jan; 148(1):77-87.e2. PubMed ID: 25280443 [TBL] [Abstract][Full Text] [Related]
3. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. Limsui D; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ J Natl Cancer Inst; 2010 Jul; 102(14):1012-22. PubMed ID: 20587792 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160 [TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer. Sanchez JA; Krumroy L; Plummer S; Aung P; Merkulova A; Skacel M; DeJulius KL; Manilich E; Church JM; Casey G; Kalady MF Br J Surg; 2009 Oct; 96(10):1196-204. PubMed ID: 19787768 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972 [TBL] [Abstract][Full Text] [Related]
7. Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study. Razzak AA; Oxentenko AS; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ Nutr Cancer; 2012; 64(7):899-910. PubMed ID: 23061900 [TBL] [Abstract][Full Text] [Related]
8. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504 [TBL] [Abstract][Full Text] [Related]
9. Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies. Phipps AI; Alwers E; Harrison T; Banbury B; Brenner H; Campbell PT; Chang-Claude J; Buchanan D; Chan AT; Farris AB; Figueiredo JC; Gallinger S; Giles GG; Jenkins M; Milne RL; Newcomb PA; Slattery ML; Song M; Ogino S; Zaidi SH; Hoffmeister M; Peters U Gastroenterology; 2020 Jun; 158(8):2158-2168.e4. PubMed ID: 32088204 [TBL] [Abstract][Full Text] [Related]
10. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability. Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826 [TBL] [Abstract][Full Text] [Related]
11. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Nagasaka T; Koi M; Kloor M; Gebert J; Vilkin A; Nishida N; Shin SK; Sasamoto H; Tanaka N; Matsubara N; Boland CR; Goel A Gastroenterology; 2008 Jun; 134(7):1950-60, 1960.e1. PubMed ID: 18435933 [TBL] [Abstract][Full Text] [Related]
12. TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers. Shima K; Morikawa T; Yamauchi M; Kuchiba A; Imamura Y; Liao X; Meyerhardt JA; Fuchs CS; Ogino S PLoS One; 2011; 6(9):e25062. PubMed ID: 21949851 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263 [TBL] [Abstract][Full Text] [Related]
15. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Imamura Y; Lochhead P; Yamauchi M; Kuchiba A; Qian ZR; Liao X; Nishihara R; Jung S; Wu K; Nosho K; Wang YE; Peng S; Bass AJ; Haigis KM; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S Mol Cancer; 2014 May; 13():135. PubMed ID: 24885062 [TBL] [Abstract][Full Text] [Related]
16. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444 [TBL] [Abstract][Full Text] [Related]
17. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers. Bond CE; Umapathy A; Ramsnes I; Greco SA; Zhen Zhao Z; Mallitt KA; Buttenshaw RL; Montgomery GW; Leggett BA; Whitehall VL Int J Cancer; 2012 Apr; 130(7):1567-76. PubMed ID: 21557216 [TBL] [Abstract][Full Text] [Related]
18. Evaluation and identification of factors related to Lin L; Chen GY; Xu CW; Wang HY; Wu YF; Fang MY J Cancer Res Ther; 2016 Dec; 12(Supplement):C191-C198. PubMed ID: 28230016 [TBL] [Abstract][Full Text] [Related]
19. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226 [TBL] [Abstract][Full Text] [Related]
20. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer. Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]